XETRA - Delayed Quote EUR

IDEXX Laboratories, Inc. (IX1.DE)

505.00 +7.70 (+1.55%)
As of 10:54 AM GMT+2. Market Open.
Loading Chart for IX1.DE
DELL
  • Previous Close 497.30
  • Open 500.60
  • Bid 498.80 x --
  • Ask 505.60 x --
  • Day's Range 500.60 - 505.00
  • 52 Week Range 349.20 - 535.60
  • Volume 35
  • Avg. Volume 15
  • Market Cap (intraday) 41.939B
  • Beta (5Y Monthly) 1.27
  • PE Ratio (TTM) 53.16
  • EPS (TTM) 9.50
  • Earnings Date Jul 30, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

www.idexx.com

11,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IX1.DE

Performance Overview: IX1.DE

Trailing total returns as of 5/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IX1.DE
0.32%
S&P 500
11.18%

1-Year Return

IX1.DE
11.73%
S&P 500
26.51%

3-Year Return

IX1.DE
18.60%
S&P 500
28.86%

5-Year Return

IX1.DE
26.69%
S&P 500
39.42%

Compare To: IX1.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IX1.DE

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    41.30B

  • Enterprise Value

    41.92B

  • Trailing P/E

    52.37

  • Forward P/E

    49.51

  • PEG Ratio (5yr expected)

    5.16

  • Price/Sales (ttm)

    12.18

  • Price/Book (mrq)

    28.45

  • Enterprise Value/Revenue

    12.23

  • Enterprise Value/EBITDA

    36.68

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    23.26%

  • Return on Assets (ttm)

    22.63%

  • Return on Equity (ttm)

    71.91%

  • Revenue (ttm)

    3.72B

  • Net Income Avi to Common (ttm)

    866.57M

  • Diluted EPS (ttm)

    9.50

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    397.43M

  • Total Debt/Equity (mrq)

    68.13%

  • Levered Free Cash Flow (ttm)

    733.09M

Research Analysis: IX1.DE

Company Insights: IX1.DE

Research Reports: IX1.DE

People Also Watch